US Patent Issued to Dechra on March 4 for "Ultra-long acting insulin-Fc fusion protein and methods of use" (Massachusetts Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,240,881, issued on March 4, was assigned to Dechra Ltd. (Skipton, Great Britain).

"Ultra-long acting insulin-Fc fusion protein and methods of use" was invented by Thomas M. Lancaster (Wenham, Mass.) and Todd C. Zion (Marblehead, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compositions of insulin-Fc fusion proteins and their use to treat feline diabetes."

The patent was filed on Oct. 13, 2023, under Application No. 18/486,310.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&...